סוטנט 37.5 מ"ג - Sutent 37.5 mg
ש××× ×× !
×תר××¤× × ×¢××× ×:×××ר ×תר×פ×ת ×©× ××©×¨× ××ר×××ת.
×× ×תק××× ××××¢× ×¢× ×פסקת ש×××ק ×תר××¤× ×:×ער×ת ×××××¢×ת ×¢× ×פסקת ש×××ק תר×פ×ת.
ת×ר×× ×¢×××× ××ר×× ×תר××¤× ×× ×××ק×תר×פ×ת ××× 15/05/15.
×תר××¤× × ×¢××× ×:×××ר ×תר×פ×ת ×©× ××©×¨× ××ר×××ת.
×× ×תק××× ××××¢× ×¢× ×פסקת ש×××ק ×תר××¤× ×:×ער×ת ×××××¢×ת ×¢× ×פסקת ש×××ק תר×פ×ת.
ת×ר×× ×¢×××× ××ר×× ×תר××¤× ×× ×××ק×תר×פ×ת ××× 15/05/15.
× ×ª×× × ×ª×¨×פ×
×××¨×©× 
| ××× ×× ×× × ×ספ×× | ||||||
|---|---|---|---|---|---|---|
| ק×××¦× ×¤×¨×ק×××××ת (ATC4) | L01EX Other protein kinase inhibitors | |||||
| ×ר××× ×¤×¢×× (ATC5) | Â
| |||||
| צ×רת ××ª× | פ××× - PER OS | |||||
| צ×רת ××× ×× | קפס×××ת, CAPSULES ××× ×עת ××× ×× ×תר ×× ×רע×× ×ש ××××× ×ת ×תר××¤× ××ת×× ×××× ×× ××××××¥ ××¤× ×©××פ××¢ ××¢××× ×צר×× | |||||
| ×ת×××× | Sutent is indicated for the treatment of gastrointestinal stromal tumor after disease progression on or intolerance to imatinib mesylate. Sutent is indicated for the treatment of advanced renal cell carcinoma.Treatment of unresectable or metastatic, well differentiated pancreatic neuroendocrine tumours (pNET) with disease progression.
| |||||
× ×ª×× × ×¡× [ ×צ×× ]
| ||||||
| ×¢××× ×ר××¤× ××××ר×ת ××¢××× |
××× ×¢××× ×ר××¤× | |||||
| ×¢××× ×צר×× |  |
|---|
| ער××× ××××ק×רפ××× | ער××× ×§×©×ר×× ××××ק×רפ××× |
|---|---|
| [ ס××× × 37.5 ×"×] ××××ר ××©×¨× ××ר×××ת |
| ××פ×ש ×××ר×× | ×××ר×× ×-PubMed |
|---|---|
| ××××¢ ×רשת | RxList WebMD Drugs.com |
| ×©× ××¦×¨× | PFIZER ITALIA S.R.L., ITALY |
| ×©× ××¢× ×ר×ש×× | PFIZER PHARMACEUTICALS ISRAEL LTD |
| ר×ש××× | ת×ר×× ××ש×: 06/2009. ר×ש××× ×ת×ר××: 01/2015 |
| ת×ר×× ×¢×××× ××ר×× | 15/05/15 |